Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Werewolf Therapeutics (HOWL) Interest Coverage Ratio (2023 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Interest Coverage Ratio for 3 consecutive years, with 11.73 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 14.81% to 11.73 in Q3 2025 year-over-year; TTM through Sep 2025 was 13.85, a 8.01% increase, with the full-year FY2024 number at 15.81, down 22.5% from a year prior.
  • Interest Coverage Ratio was 11.73 for Q3 2025 at Werewolf Therapeutics, up from 13.48 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 6.35 in Q2 2023 to a low of 71.06 in Q1 2023.
  • A 3-year average of 18.41 and a median of 13.77 in 2024 define the central range for Interest Coverage Ratio.
  • Biggest YoY gain for Interest Coverage Ratio was 75.92% in 2024; the steepest drop was 161.34% in 2024.
  • Werewolf Therapeutics' Interest Coverage Ratio stood at 12.83 in 2023, then dropped by 25.14% to 16.06 in 2024, then grew by 26.98% to 11.73 in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Interest Coverage Ratio are 11.73 (Q3 2025), 13.48 (Q2 2025), and 14.24 (Q1 2025).